Grace Therapeutics (GRCE) Non Operating Interest Expenses (2011 - 2019)
Grace Therapeutics (GRCE) posted Non Operating Interest Expenses of -$834,847 for fiscal Q1 2020 (quarter ended Jun 30, 2019), compared with $1.94 million a year earlier.
Grace Therapeutics (GRCE) Non Operating Interest Expenses (2011 - 2019) Analysis & Trends
For the trailing twelve months through Jun 30, 2019, Non Operating Interest Expenses at Grace Therapeutics was $2.05 million, down 31.7% year-over-year; for FY2018 (ended Mar 31, 2018), it came in at -$1.41 million.
- In prior fiscal years, Grace Therapeutics' Non Operating Interest Expenses was -$87,703 in FY2017, -$2,261 in FY2016, $4,000 in FY2015 (-99.6%) and $1.12 million in FY2014.
- The fiscal Q1 2020 figure stands as the lowest quarterly Non Operating Interest Expenses in data going back to fiscal Q1 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -834,847.33 |
| Jun 30, 2018 | 1.94 Mn |
| Mar 31, 2018 | -11,868.06 |
| Dec 31, 2017 | 960,313.54 |
| Sep 30, 2017 | 116,421.33 |
| Jun 30, 2017 | 84,039.97 |
| Nov 30, 2016 | -1,245.00 |
| Aug 31, 2016 | -2,462.00 |
| May 31, 2016 | -287,092.00 |
| Feb 29, 2016 | -176,000.00 |
| Nov 30, 2015 | -87,000.00 |
| Aug 31, 2015 | -1,028.00 |
| May 31, 2015 | -86,412.00 |
| Feb 28, 2015 | 2,000.00 |
| Nov 30, 2014 | -944.00 |
| Aug 31, 2014 | -319,483.00 |
| May 31, 2014 | -335,357.00 |
| Feb 28, 2014 | 1.07 Mn |
| Nov 30, 2013 | -551,578.00 |
| Aug 31, 2013 | -652.00 |
Grace Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();